N-Methyl-N-(3-(((2-((2-oxoindolin-5-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)methyl)pyridin-2-yl)methanesulfonamide methanesulfonate

Catalog No. :
ACQIQP727
CAS No. :
939791-39-6
Molecular Formula :
C22H24F3N7O6S2
Molecular Weight :
603.60

IUPAC Name:N-methyl-N-(3-(((2-((2-oxoindolin-5-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)methyl)pyridin-2-yl)methanesulfonamide methanesulfonate

N-Methyl-N-(3-(((2-((2-oxoindolin-5-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)methyl)pyridin-2-yl)methanesulfonamide methanesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-N-(3-(((2-((2-oxoindolin-5-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)methyl)pyridin-2-yl)methanesulfonamide methanesulfonate
IUPAC NameN-methyl-N-(3-(((2-((2-oxoindolin-5-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)methyl)pyridin-2-yl)methanesulfonamide methanesulfonate
Molecular FormulaC22H24F3N7O6S2
Molecular Weight603.60
SMILESO=C1NC2=CC=C(C=C2C1)NC3=NC=C(C(=N3)NCC4=CC=CN=C4N(C)S(=O)(=O)C)C(F)(F)F.O=S(=O)(O)C
InChI KeyLMGBAHJMBMDBFE-UHFFFAOYSA-N
SynonymPF-562271 mesylate
CAS No.939791-39-6

Synthetic Route by SureRoute

1. ACQIQP727 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJLMI673 route compound structure diagram
    ACJLMI673939791-42-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQIQP727 route product structure diagram
    ACQIQP727939791-39-6
Inquiry

2. ACQIQP727 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYCLA179 route compound structure diagram
    ACYCLA17920870-78-4 In Stock
  4. Then
  5. ACQIQP727 route product structure diagram
    ACQIQP727939791-39-6
Inquiry

Comments (0)